Flexion Therapeutics, Inc. Forms 3, 4 and 5: Other

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 6 rows, 6 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

2017-06-26: Reporting owner Levine Mark S.; Form 3; Security No securities are beneficially owned.; Transaction Holding.
2017-04-05: Reporting owner Deniz Yamo; Form 3; Security No securities are beneficially owned; Transaction Holding.
2014-07-24: Reporting owner Mahatme Sandesh; Form 3; Security No securities are beneficially owned.; Transaction Holding.
2014-06-13: Reporting owner MERRIFIELD C ANN; Form 3; Security No securities are beneficially owned.; Transaction Holding.

All rows

Transaction date	Reporting owner	Form	Security	Transaction	Shares	Price	Filing
2017-06-26 holding as of filing	Levine Mark S. Officer (SVP & General Counsel)	3	No securities are beneficially owned. Non-derivative · Direct	Holding	0 owned after	no price filed	2017-06-26
2017-04-05 holding as of filing	Deniz Yamo Officer (Chief Medical Officer)	3	No securities are beneficially owned Non-derivative · Direct	Holding	0 owned after	no price filed	2017-04-05
2014-07-24 holding as of filing	Mahatme Sandesh Director	3	No securities are beneficially owned. Non-derivative · Direct	Holding	0 owned after	no price filed	2014-07-24
2014-06-13 holding as of filing	MERRIFIELD C ANN Director	3	No securities are beneficially owned. Non-derivative · Direct	Holding	0 owned after	no price filed	2014-06-13
2014-02-11 holding as of filing	Lukatch Heath Director	3	No securities are beneficially owned. Non-derivative · Direct	Holding	0 owned after	no price filed	2014-02-11
2014-02-11 holding as of filing	Jones Elaine V Director	3	No securities are beneficially owned. Non-derivative · Direct	Holding	0 owned after	no price filed	2014-02-11